期刊文献+

胎球蛋白A与动脉粥样硬化关系的研究进展

Research Progress of Relationship between Fetuin-A and Atherosclerosis
下载PDF
导出
摘要 动脉粥样硬化(As)是多种心血管疾病的病理学基础,发病机制复杂且目前尚未完全阐明。肝脏因子与心血管疾病的发生、发展有一定关联,胎球蛋白A(FA)即为其中一种。FA在人体正常生理和病理生理过程中发挥多种作用,因此,血清FA水平与脂质紊乱、糖尿病和心血管疾病等疾病的发生密切相关。FA可能通过诱导胰岛素抵抗、抑制血管钙化及促进血管内皮细胞炎症反应等多种机制对As的发生发展发挥双向作用,早期促进As的发病,而晚期则可能在As发展中起保护作用。 Atherosclerosis(As)is the pathological basis of many cardiovascular diseases,and its pathogenesis is complex and has not yet been fully elucidated.Hepatokines are associated with the occurrence and development of cardiovascular diseases,and fetuin-A(FA)is one of them.FA plays a variety of roles in the normal physiological and pathophysiological processes in the human body.Therefore,serum FA levels are closely related to the occurrence of many diseases such as lipid disorders,diabetes and cardiovascular diseases.FA may play a two-way role in the development of As,which promotes the onset of As in the early stage,and may play a protective role in the development of As in the late stage,by inducing insulin resistance,inhibiting vascular calcification and promoting vascular endothelial cell inflammation response.
作者 张智慧 李连喜 ZHANG Zhihui;LI Lianxi(Department of Endocrinology and Metabolism,Shanghai Jiaotong University Affiliated Sixth People′s Hospital/Shanghai Clinical Center for Diabetes/Shanghai Diabetes Institute/Shanghai Key Laboratory of Diabetes,Shanghai 200233,China)
出处 《医学综述》 2019年第21期4161-4165,4173,共6页 Medical Recapitulate
基金 国家重点研发计划及子课题(2018YFC1314900,2018YFC1314905) 国家自然科学基金(81770813) 上海市科研计划项目(15411960600)
关键词 动脉粥样硬化 肝脏因子 胎球蛋白A 血管钙化 胰岛素抵抗 Atherosclerosis Hepatokine Fetuin-A Vascular calcification Insulin resistance
  • 相关文献

参考文献5

二级参考文献67

  • 1王宓,王梅,甘良英,李四君,张萌.血液透析患者血浆胎球蛋白A水平及其与血管钙化的关系[J].中国血液净化,2007,6(5):263-266. 被引量:22
  • 2Rasul S, Wagner L, Kautzky-Willer A. Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus [J] . Endocrine, 2012, 42 (3): 496-505.
  • 3Stefan N, Wiring HU. The role of hepatokines in metabolism[J]. Nat Rev Endocrinol, 2013, 9 (3): 144-152.
  • 4Haukeland JW, Dahl TB, Yndestad A, et al . Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies[J]. Eur J Endocrinol, 2012,166(3): 503-510.
  • 5Schultes B, Frick J, Ernst B, et al. The effect of 6-weeks of aerobic exercise training on serum fetuin-A levels in nondiabetic obese women [J]. Exp Clin Endocrinol Diabetes, 2010, 118 (10): 754-756.
  • 6Song A, Xu M, Bi Y, et al. Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults [J] . PLoS One, 2011, 6(4): el9228.
  • 7Ou HY, Yang YC, Wu HT, et al . Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes [J]. Clin Endocrinol (Oxf) , 2011, 75 (4): 450-455.
  • 8Ix JH, Biggs ML, Mukamal KJ, et al. Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study[J]. Circulation, 2012, 125 (19): 2316-2322.
  • 9Laughlin GA, Barrett-Connor E, Cummins KM, et al, The sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the rancho bernardo study[J]. Diabetes Care, 2013 Jan 11. [Epub ahead of print] PMID: 23315604.
  • 10Sun Q, Cornelis MC, Manson JE, et al. Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S [J]. Diabetes, 2013, 62 (1): 49-55.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部